Home › Bayer Submits New Drug Application for Riociguat for the Treatment of ...
 

Keywords :   


Bayer Submits New Drug Application for Riociguat for the Treatment of ...

2013-02-13 12:56:21| Chemicals - Topix.net

Bayer HealthCare today announced that the company has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for riociguat, an investigational compound for the treatment of pulmonary arterial hypertension and persistent/recurrent chronic thromboembolic pulmonary hypertension after surgical treatment or inoperable ... (more)

Tags: the of application treatment

Category:Chemicals

Latest from this category

All news
25.11PPG Recognized in Newsweeks Americas Greenest Companies List
25.11Axalta Wins Another Distinguished R&D 100 Award for Innovation
25.11Dunn-Edwards CEO Karl Altergott to Retire, COO Monte Lewis is Successor
25.11Global Market Insights: Auto Refinish Coating Market $17.79 Billion by 2032
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
Chemicals »
26.11
26.11HG
26.11&
26.11 XL Dime Final Jersey Navy
26.11-o SAPIX 4
26.11
26.112
26.11CUH-2000b PlayStation4
More »